New Podcast Discusses Maintenance Rituximab for Waldenström Macroglobulinemia

On the latest episode of the Oncology Learning Network’s podcast, Blood Bytes, Steven Treon, MD, PhD, Director of the Bing Center for Waldenström’s macroglobulinemia at the Dana-Farber Cancer Institute, and Professor of Medicine at Harvard Medical School, Boston and Christian Buske, Medical Director at the Comprehensive Cancer Center and the Institute of Experimental Cancer Research at the University Ulm, Germany provide an overview of the use of rituximab maintenance for patients with Waldenström macroglobulinemia.

Listen here.